首页|期刊导航|中国实验方剂学杂志|中医药基于Nrf2信号通路改善糖尿病视网膜病变的研究进展

中医药基于Nrf2信号通路改善糖尿病视网膜病变的研究进展OA

Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway

中文摘要英文摘要

糖尿病视网膜病变(DR)是糖尿病引发的微血管病变,也是糖尿病较为常见的并发症之一,长期高糖环境可引起氧化应激、炎症反应、细胞凋亡和病理性血管形成,最终破坏血-视网膜屏障(BRB),导致视力损害甚至失明.近年来研究发现,核因子红系2相关因子2(Nrf2)信号通路在DR的病理进程中发挥关键作用,同时中药单体通过调控Nrf2信号通路干预DR的发展.在抑制氧化应激方面,桔梗皂苷-D、人参皂苷Rb1等皂苷类化合物通过下调丙二醛(MDA)的表达,改善视网膜氧化应激状态;葛花总黄酮、葛根素等黄酮类化合物通过上调超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)等的表达,有效地清除脂质过氧化物.在抑制炎症方面,白藜芦醇、绿原酸等酚类化合物通过抑制核转录因子-κB(NF-κB)信号通路减少肿瘤坏死因子-α(TNF-α)的释放,减轻炎症反应.在抑制细胞凋亡方面,黄精多糖、当归多糖等多糖类化合物通过下调细胞凋亡蛋白B细胞淋巴瘤-2(Bcl-2)相关X蛋白(Bax)表达及抑制细胞凋亡胱天蛋白酶-3(Caspase-3)活性,减少细胞凋亡率.在抑制新生血管生成方面,白果内酯、大黄素甲醚等化合物可显著降低血管内皮生长因子(VEGF)的蛋白表达,减少视网膜新生血管形成.通络驻景丸、益气活血养阴汤、芪明颗粒、丹蒌片等中药复方亦能通过上述机制干预DR的发生发展.所以,中药单体及复方通过调控Nrf2信号通路,可从抑制氧化应激、减轻炎症反应等多方面参与维持BRB完整性、抑制视网膜新生血管生成及神经变性,从而延缓DR进程.因此,通过对近年来国内外运用中医药治疗DR相关的作用机制研究及Nrf2信号通路对DR的影响进行整理和综述,以期为DR的防治提供一定的研究思路.

Diabetic retinopathy(DR)is a microvascular complication of diabetes and one of its most common complications.Prolonged hyperglycemia induces oxidative stress,inflammatory responses,apoptosis,and pathological angiogenesis,ultimately disrupting the blood-retinal barrier(BRB)and leading to visual impairment or even blindness.Recent studies show that the nuclear factor erythroid 2-related factor 2(Nrf2)signaling pathway plays an important role in the development of DR's pathological changes.Meanwhile,Chinese herbal monomers have been shown to modulate the Nrf2 signaling pathway,thereby intervening in the development of DR.In terms of inhibiting oxidative stress,saponin compounds such as platycodin-D and ginsenoside Rb1 downregulate the expression of malondialdehyde(MDA),thereby ameliorating retinal oxidative stress.Flavonoids such as total flavonoids from Pueraria lobata flower and puerarin upregulate the expression of superoxide dismutase(SOD)and glutathione peroxidase(GPx),effectively clearing lipid peroxides.Regarding the suppression of inflammation,phenolic compounds like resveratrol and chlorogenic acid inhibit the nuclear factor kappa B(NF-κB)pathway,reducing the release of tumor necrosis factor-alpha(TNF-α)and mitigating inflammatory responses.In the context of inhibiting apoptosis,polysaccharides such as Polygonatum sibiricum polysaccharide and Angelica sinensis polysaccharide downregulate the expression of the pro-apoptotic protein Bcl-2-associated X protein(Bax)and suppress the activity of the executioner Caspase-3,thereby reducing the apoptosis rate.As for the inhibition of neovascularization,compounds including bilobalide and physcion significantly decrease the protein expression of vascular endothelial growth factor(VEGF),leading to a reduction in retinal pathological angiogenesis.Furthermore,Chinese herbal compound prescriptions such as Tongluo Zhujing pills,Yiqi Huoxue Yangyin decoction,Qiming granules,and Danlou tablets can also intervene in the onset and progression of DR through the mechanisms described above.In summary,both Chinese herbal monomers and Chinese herbal compound prescriptions can modulate the Nrf2 signaling pathway to inhibit oxidative stress,alleviate inflammation,and participate in maintaining BRB integrity,suppressing retinal neovascularization,and preventing neurodegeneration,thereby delaying the progression of DR.Therefore,this paper reviews and summarizes recent studies at home and abroad on how traditional Chinese medicine(TCM)works to treat DR,and the relationship between the Nrf2 pathway and DR.It aims to provide research ideas for preventing and treating DR.

刘雪晴;钟欣妤;王亭亭;王宁;刘满;吴丽;吴丽丽;秦灵灵;刘铜华

河南中医药大学 中医药科学院,郑州 450046||北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029||陕西中医药大学,陕西 咸阳 712046北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029||陕西中医药大学,陕西 咸阳 712046北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029||北京中医药大学 中医学院,北京 102488河南中医药大学 中医药科学院,郑州 450046||北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029||陕西中医药大学,陕西 咸阳 712046北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029北京中医药大学 科技处,北京 100029北京中医药大学,教育部中医养生学重点实验室,北京 100029||北京中医药大学,中医养生学北京市重点实验室,北京 100029

医药卫生

糖尿病视网膜病变核因子红系2相关因子2(Nrf2)信号通路中药单体中药复方研究进展

diabetic retinopathynuclear factor erythroid 2-related factor 2(Nrf2)signaling pathwayChinese herbal monomersChinese herbal compound prescriptionsresearch progress

《中国实验方剂学杂志》 2026 (9)

69-78,10

教育部科技部2020年度新建高等学校学科创新引智基地项目(B20055)

10.13422/j.cnki.syfjx.20260322

评论